Reply to Marakasova and Baranova, "MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection"

mBio. 2021 Feb 2;12(1):e03682-20. doi: 10.1128/mBio.03682-20.

Authors

Jeffrey E Gold¹, David J Hurley², Balázs Rada², William H Baumgartl³, Larry P Tilley⁴, Warren E Licht⁵

Affiliations

¹ World Organization, Watkinsville, Georgia, USA jeff_gold@world.org.
² College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
³ Nevada Spine Center, Las Vegas, Nevada, USA.
⁴ VetMed Consultants, Inc., Santa Fe, New Mexico, USA.
⁵ Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Complement Activation
Humans
Measles* / prevention & control
Measles-Mumps-Rubella Vaccine
Mumps*
Rubella*
SARS-CoV-2

Substances

Measles-Mumps-Rubella Vaccine